First U.S. Shipments of Pfizer Vaccine Will Be 2.9 Million Doses

About This Source - Bloomberg QuickTake: Now

Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City.

It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.

Recent from Bloomberg QuickTake: Now:

  • Myanmar Coup: Protesters Plan Biggest Rallies Yet After 2 Shot Dead
  • Christchurch Earthquake: New Zealand PM Ardern Honors Victims at Memorial Service
  • Italy Unveils Coronavirus Memorial to Mark One Year Since Its First Case
  • Bloomberg Quicktake: Now published this video item, entitled “First U.S. Shipments of Pfizer Vaccine Will Be 2.9 Million Doses” – below is their description.

    Less than half of the available 6.4 million doses of Pfizer Inc.’s Covid-19 vaccine will be initially sent out to states, and 500,000 will be held separately in reserve by the government, according to a top official at Operation Warp Speed.

    Gustave Perna, the army general who serves as Warp Speed’s chief operating officer, said on a call with reporters Wednesday that the U.S. plans to distribute 2.9 million doses in the first round of shipments following authorization of Pfizer’s still-experimental vaccine. The rest will be held back to be distributed to states and other jurisdictions when the first people vaccinated are due for their second dose 21 days later.

    The half a million shots in reserve will be ready for unforeseen circumstances, Perna said, calling the move “good army general officer planning.”

    The government has declined to say in detail how many doses will be allocated to each state and other jurisdictions, including large cities. Shots will be allocated based on the states’ adult populations, officials have said.

    “As we get more experienced on quality of control on the production, we’ll get greater confidence, of course, in the level of supply reserve we hold back for that second-dose administration,” Health and Human Services Secretary Alex Azar said during the briefing. “But we will not distribute a vaccine knowing that the booster will not be available.”

    Azar said the government still projected there will be enough supply available to deliver 20 million initial doses in December.

    States received a slew of numbers in recent weeks on how many doses they should expect without much explanation, making it difficult for them to plan. In late November they were told 6.4 million doses of Pfizer’s vaccine candidate would be available at first, and 12.5 million of Moderna Inc.’s shot after it is authorized.

    Bloomberg Quicktake: Now YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Australians across the nation receive the COVID-19 vaccine | 7NEWS
  • Sinopharm’s COVID-19 vaccine production capacity to exceed 1 billion in 2021
  • UK pushes ambitious COVID-19 vaccine plan
  • Frontline workers set to get vaccine, Prince Philip’s hospital uncertainty | 9 News Australia
  • Female Taxi Driver in S. Africa: I must be stronger amid COVID-19
  • In This Story: Moderna

    Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

    CEO: Stéphane Bancel (2011–)

    Stock ticker: (NASDAQ:MRNA)

    5 Recent Items: Moderna

  • Biden Blames Trump for Failing to Order Enough Covid Vaccines for U.S.
  • LIVE: Biden Speaks at Pfizer’s Vaccine Manufacturing Site in Kalamazoo, Michigan
  • Coronavirus: BC Premier John Horgan set to speak to reporters on Thursday | LIVE
  • Coronavirus pandemic: EU buys up to 300 million more Moderna jabs
  • White House advisor: Vaccines may be less effective against variants, but still above threshold
  • In This Story: Pfizer

    Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

    5 Recent Items: Pfizer

  • Australia’s vaccine rollout, tennis crowd’s vaccine anger | 9 News Australia
  • COVID Australia: Pfizer COVID-19 vaccination program officially commences in New South Wales | 7NEWS
  • COVID Australia: South Australians receive the Pfizer coronavirus vaccine | 7NEWS
  • #LIVE: Victorian Health Minister Martin Foley giving a COVID-19 update | ABC News
  • Coronavirus: Pfizer vaccine rolls out across Australia | 9 News Australia
  • Leave a Comment